Tenpoint Therapeutics is an ophthalmology-focused biotech company developing eye treatments aimed at restoring vision in aging eyes. The company emphasizes presbyopia, cataract-related vision issues, and geographic atrophy, partnering with eye care professionals to redefine presbyopia care and improve near-vision performance. Headquartered in London with a global perspective, Tenpoint Therapeutics highlights a pipeline of innovative therapies and a commitment to real-world needs in eye care.
No recent deals for this company.